Skip to Main Content

Paper Details

Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration.
Sci Transl Med
135
2017
AMD, CFI, Geographic atrophy, Lampalizumab, age-related macular degeneration, associated genetic polymorphisms, complement factor D, complement factor I, factor D, geographic atrophy, lampalizumab, patients, vision loss
Author NameAffiliation
Brian L YaspanGenentech Inc.
Frank G HolzUniversity of Bonn
Robert R GrahamGenentech Inc.
Robert R GrahamGenentech Inc.
Tushar BhangaleGenentech Inc.
Tushar BhangaleGenentech Inc.
Lee A HonigbergGenentech Inc.
Ashley SmithGenentech Inc.
  • 1 - 8

Datasets

Release 1.2